Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22.5M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
497K
-
Shares change
-
-91.1K
-
Total reported value, excl. options
-
$120K
-
Value change
-
-$72.5K
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$0.24
Significant Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q2 2025
16 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q2 2025.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 497K shares
of 22.5M outstanding shares and own 2.21% of the company stock.
Largest 10 shareholders include HRT FINANCIAL LP (174K shares), CITADEL ADVISORS LLC (121K shares), UBS Group AG (74.7K shares), GEODE CAPITAL MANAGEMENT, LLC (54.2K shares), Ground Swell Capital, LLC (27.6K shares), RENAISSANCE TECHNOLOGIES LLC (23.9K shares), GOLDMAN SACHS GROUP INC (13.4K shares), Tower Research Capital LLC (TRC) (6.15K shares), SBI Securities Co., Ltd. (1.1K shares), and RAYMOND JAMES FINANCIAL INC (910 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.